Sökning: "clinical protection"
Visar resultat 1 - 5 av 290 avhandlingar innehållade orden clinical protection.
1. Cardiac effects of non-adrenergic inotropic drugs : clinical and experimental studies
Sammanfattning : Background: Myocardial failure and dysfunction is not uncommon during critical illness and following cardiac surgery. For optimal treatment, a better understanding of the effects of inotropic drugs is needed. In this thesis, two non-adrenergic mediated inotropes, milrinone and levosimendan were studied in different models of myocardial dysfunction. LÄS MER
2. Autonomic cardiac control in long QT syndrome : clinical studies of arrhythmogenic triggers
Sammanfattning : Background: Long QT syndrome (LQTS) is an inherited cardiac disease characterized by prolonged cardiac repolarization and an increased risk for life-threatening arrhythmias. These arrhythmias are typically triggered by adrenergic stimuli, such as physical activity and intense emotions, implicating that the sympathetic part of the autonomic nervous system (ANS) is involved in arrhythmogenesis. LÄS MER
3. Experimental acute otitis media : aspects on treatment, protection and structural changes
Sammanfattning : Acute otitis media (AOM) is a common disease in childhood and is one of the most common causes for outpatient antibiotic treatment. The major aetiological agents of AOM have varied over the decades. Now the three most common pathogens are Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. LÄS MER
4. Bacterial meningitis in children : clinical aspects and preventive effects of vaccinations
Sammanfattning : Bacterial meningitis, one of the most severe infections a child can contract, can be caused by several different strains of bacteria. Most commonly, Haemophilus influenzae type b (Hib), Streptococcus pneumoniae and Neisseria meningitidis. LÄS MER
5. Development and evaluation of new generation vaccines against bovine respiratory syncytial virus
Sammanfattning : Bovine respiratory syncytial virus (BRSV) is a major cause of respiratory disease in cattle worldwide. Improved BRSV vaccines are needed, with better efficacy and longer duration of protection, in particular when used in calves with specific maternally derived antibodies (MDA). LÄS MER